These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7843592)
1. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. Rossetti L; Barbieri P; Velati P; Bujtar E; Orzalesi N Graefes Arch Clin Exp Ophthalmol; 1994 Nov; 232(11):670-4. PubMed ID: 7843592 [TBL] [Abstract][Full Text] [Related]
2. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy? Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114 [TBL] [Abstract][Full Text] [Related]
3. A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure. Albracht DC; LeBlanc RP; Cruz AM; Lamping KA; Siegel LI; Stern KL; Kelley EP; Stoecker JF Am J Ophthalmol; 1993 Sep; 116(3):307-13. PubMed ID: 8357055 [TBL] [Abstract][Full Text] [Related]
4. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. Ober M; Scharrer A; Dausch D Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660 [TBL] [Abstract][Full Text] [Related]
5. Effect of adding betaxolol to dipivefrin therapy. Weinreb RN; Ritch R; Kushner FH Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535 [TBL] [Abstract][Full Text] [Related]
6. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans. Gandolfi SA; Vecchi M Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970 [TBL] [Abstract][Full Text] [Related]
7. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure]. Ober M; Scharrer A Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479 [TBL] [Abstract][Full Text] [Related]
8. Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. Widengård I; Mäepea O; Alm A Br J Ophthalmol; 1998 Apr; 82(4):404-6. PubMed ID: 9640189 [TBL] [Abstract][Full Text] [Related]
9. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Michaud JE; Friren B; Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685 [TBL] [Abstract][Full Text] [Related]
10. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study. Schenker HI; Silver LH Am J Ophthalmol; 2000 Aug; 130(2):145-50. PubMed ID: 11004287 [TBL] [Abstract][Full Text] [Related]
11. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product]. Yamamoto T; Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Silver LH Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373 [TBL] [Abstract][Full Text] [Related]
14. Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study. Kass MA; Mandell AI; Goldberg I; Paine JM; Becker B Arch Ophthalmol; 1979 Oct; 97(10):1865-6. PubMed ID: 39539 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA; Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group. Boyle JE; Ghosh K; Gieser DK; Adamsons IA Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline. Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Boyle JE; Ghosh K; Gieser DK; Adamsons IA Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692 [TBL] [Abstract][Full Text] [Related]
19. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group. March WF; Ochsner KI Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964 [TBL] [Abstract][Full Text] [Related]
20. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma. Drake MV; Wilson MR; Harris D; Goodwin L J Ocul Pharmacol; 1993; 9(2):91-5. PubMed ID: 8123096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]